Back to Journals » Drug Design, Development and Therapy » Volume 11

N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Total article views   Abstract views HTML views PDF downloads Totals
9,211 Dovepress* 7,488 1,387+ 1,567 8,875
PubMed Central* 0 336 106 336
Totals 7,488 1,723 1,673 9,211
*Since 17 January 2017
+Since July 2016

View citations on PubMed Central and Google Scholar